Operating profit EBITDA: medicuspharma.com (MDCX)

Graphic logo of medicuspharma.com (MDCX)

Medicus Pharma Ltd. (MDCX) faces significant challenges due to its reliance on a single drug and fierce competition. The gross operating profit before depreciation trend on this GURU.Markets service chart clearly illustrates financial stability, where 0.00 determines the latest valuation metric. Simultaneously, Medicus Pharma Ltd. (MDCX) is developing targeted skin cancer treatments and implementing robotic molecule screening to accelerate drug development.

Profit before payment of interest, taxes and amortization: medicuspharma.com (MDCX) for 11/23/2025 - 11/12/2026

Medicus Pharma (MDCX) - metric breakdowns and financial figures

- stock value and consensus price forecast:
Market Chart Medicus Pharma Corp|MDCX - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization Medicus Pharma|MDCX - Enterprise Value
- book value of equity indicators:
Net Assets per Share Medicus Pharma|MDCX - Company Book Value|Capitalization to Book Value Ratio medicuspharma.com|MDCX - Aggregate Company Assets
- business debt structure and liquidity details:
Total Debt to Equity Ratio Medicus Pharma Ltd.|MDCX - Long-Term Debt to Capital|Current Liabilities to Capital Medicus Pharma Ltd|MDCX - Company Aggregate Debts|Debt to Book Value Ratio Medicus Pharma|MDCX - Company Long-Term Debts|Short-Term Debt Volume Medicus Pharma|Quick Liquidity Indicator medicuspharma.com
- company profitability and valuation multiples indicators:
MDCX - Net Income|Projected Future Earnings Medicus Pharma Ltd.|MDCX - Price to Earnings Ratio|Market Cap to Projected Earnings medicuspharma.com|MDCX - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Medicus Pharma|MDCX - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Medicus Pharma|MDCX - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months medicuspharma.com|MDCX - Earnings growth in current year|Earnings growth forecast for next year Medicus Pharma Ltd.
Summary company analytics:Medicus Pharma Corp - MDCX
Mass-produced product of Medicus Pharma Ltd.

An analysis of the operating cash flow of Medicus Pharma Ltd. (MDCX) allows for an assessment of the sales efficiency of dermatological products, accounting for the costs of eco-friendly packaging and the removal of toxins from formulas. This indicator captures the net cash flow from core operations before depreciation, interest, and taxes, serving as a fundamental measure of the business's ability to generate real cash to ensure long-term sustainability.

Who Medicus Pharma Ltd. competes with

Operating income before deduction of amortization Krystal Biotech Corp. (KRYS)|APGE - Profit before payment of interest, taxes and amortization|ARQT - Operating profit EBITDA|VCEL: Operating profit EBITDA|ORKA - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Sanara MedTech, Inc.|Operating profit before amortization DBVT (DBV Technologies SA)|Profit before payment of interest, taxes and amortization Solesence Inc (SLSN)|Operating profit before deduction of amortization journeymedicalcorp.com DERM|Operating profit EBITDA FBRX (Forte Biosciences)|Empro Group Inc. (EMPG) - Profit before interest, taxes and amortization|Sol-Gel - Operating profit EBITDA|AXIL (AXIL Brands, Inc.) - Operating profit before amortization|VRCA: Operating profit EBITDA|HOTH - Operating income before deduction of amortization|BFRI (Biofrontera, Inc.) - Operating profit EBITDA|Operating profit before deduction of amortization VYNE Therapeutics Inc (VYNE)|Operating profit before deduction of amortization SNOA (Sonoma Pharmaceuticals)|Operating profit EBITDA quoinpharma.com (QNRX)|Profit before payment of interest, taxes and amortization Azitra, Inc. AZTR|Operating income before deduction of amortization dermatarx.com (DRMA)|ELAB: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization RVNC (Revance Therapeutics Inc.)